Earnings Beat: UnitedHealth Group delivered stronger-than-expected Q2 results, with revenue and EPS surpassing analyst forecasts. The healthcare giant also raised its full-year guidance, sparking initial optimism among market observers on social media.
Price Action Shift: Following an impressive rally from its March lows, the stock has encountered resistance at key technical levels. Recent analysis highlights a rejection near the 200-week moving average, prompting discussions of a potential pullback toward support zones around 390.
Market Sentiment: Observers note the stock's defensive appeal amid broader volatility, though some highlight risks from ongoing sector pressures. Overall discussion reflects a mixed tone as investors weigh the earnings momentum against short-term chart concerns.
Note: This discussion summary was generated from an AI condensation of post data.
UnitedHealth Group Revenue
UnitedHealth Group had revenues of $112B in Q2 2026. This is an increase of 0.37% from the same period in the prior year.
You can track UNH financials on Quiver Quantitative's UNH stock page.
You can access data on UNH stock through the Quiver Quantitative API.
UnitedHealth Group Congressional Stock Trading
Members of Congress have traded $UNH stock 14 times in the past 6 months. Of those trades, 9 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:
- REPRESENTATIVE DAN NEWHOUSE sold up to $15,000 on 07/10.
- REPRESENTATIVE RICHARD MCCORMICK has traded it 3 times. They made 1 purchase worth up to $15,000 on 03/19 and 2 sales worth up to $30,000 on 06/12.
- SENATOR JOHN BOOZMAN purchased up to $15,000 on 06/04.
- REPRESENTATIVE MARIA ELVIRA SALAZAR has traded it 3 times. They made 2 purchases worth up to $30,000 on 04/22 and 1 sale worth up to $15,000 on 06/04.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. has traded it 3 times. They made 2 purchases worth up to $30,000 on 04/14, 03/13 and 1 sale worth up to $50,000 on 02/10.
- SENATOR ALAN ARMSTRONG purchased up to $50,000 on 03/27.
- SENATOR MARKWAYNE MULLIN purchased up to $100,000 on 02/25.
- REPRESENTATIVE JOSH GOTTHEIMER purchased up to $15,000 on 02/05.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
UnitedHealth Group Hedge Fund Activity
We have seen 1,564 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 1,558 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC added 12,377,403 shares (+146.6%) to their portfolio in Q1 2026, for an estimated $3,327,664,796
- CAPITAL RESEARCH GLOBAL INVESTORS added 10,850,420 shares (+173.3%) to their portfolio in Q1 2026, for an estimated $2,917,135,417
- CAPITAL INTERNATIONAL INVESTORS removed 9,653,799 shares (-51.7%) from their portfolio in Q1 2026, for an estimated $2,595,423,861
- WELLINGTON MANAGEMENT GROUP LLP removed 5,597,135 shares (-35.7%) from their portfolio in Q1 2026, for an estimated $1,504,789,744
- CAPITAL WORLD INVESTORS added 5,192,373 shares (+23.0%) to their portfolio in Q1 2026, for an estimated $1,395,969,481
- BERKSHIRE HATHAWAY INC removed 5,039,564 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,354,886,781
- FISHER ASSET MANAGEMENT, LLC added 3,844,568 shares (+73.4%) to their portfolio in Q2 2026, for an estimated $1,597,917,797
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
UnitedHealth Group Price Targets
Multiple analysts have issued price targets for $UNH recently. We have seen 18 analysts offer price targets for $UNH in the last 6 months, with a median target of $434.5.
Here are some recent targets:
- Ben Hendrix from RBC Capital set a target price of $463.0 on 07/09/2026
- Sidharth Sahoo from HSBC set a target price of $380.0 on 07/06/2026
- Erin Wright from Morgan Stanley set a target price of $468.0 on 06/30/2026
- Kevin Fischbeck from B of A Securities set a target price of $475.0 on 06/24/2026
- Whit Mayo from Leerink Partners set a target price of $462.0 on 06/17/2026
- Lisa Gill from JP Morgan set a target price of $466.0 on 06/08/2026
- Ann Hynes from Mizuho set a target price of $460.0 on 06/08/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
